Nurix Therapeutics, Inc. (NRIX)
NASDAQ: NRIX · Real-Time Price · USD
17.08
+0.59 (3.58%)
Apr 28, 2026, 4:00 PM EDT - Market closed
Nurix Therapeutics Cash Flow Statement
Financials in millions USD. Fiscal year is December - November.
Millions USD. Fiscal year is Dec - Nov.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2018 |
|---|---|---|---|---|---|---|---|
Period Ending | Feb '26 Feb 28, 2026 | Nov '25 Nov 30, 2025 | Nov '24 Nov 30, 2024 | Nov '23 Nov 30, 2023 | Nov '22 Nov 30, 2022 | Nov '21 Nov 30, 2021 | 2020 - 2018 |
| Net Income | -295.28 | -264.46 | -193.57 | -143.95 | -180.36 | -117.19 | Upgrade
|
| Depreciation & Amortization | 17.9 | 18.26 | 15.13 | 12.25 | 9.61 | 5.28 | Upgrade
|
| Other Amortization | 0.6 | 0.6 | 1.3 | 1.4 | 1.2 | 0.8 | Upgrade
|
| Loss (Gain) From Sale of Assets | 0.25 | 0.09 | 0.03 | 0.56 | 0.01 | 0.13 | Upgrade
|
| Loss (Gain) From Sale of Investments | -8.74 | -10.32 | -11.29 | -5.42 | 0.43 | 1.71 | Upgrade
|
| Stock-Based Compensation | 38.65 | 37.97 | 33.93 | 33.67 | 28.13 | 15.8 | Upgrade
|
| Other Operating Activities | - | - | 0.29 | - | 0.2 | - | Upgrade
|
| Change in Accounts Receivable | - | - | - | - | 6 | -6 | Upgrade
|
| Change in Accounts Payable | 2.12 | -0.63 | 5.21 | 1.61 | 0.09 | 1.59 | Upgrade
|
| Change in Unearned Revenue | -28.41 | -36.98 | -28.55 | 19.51 | -26.63 | 14.25 | Upgrade
|
| Change in Income Taxes | - | - | - | - | - | 3.64 | Upgrade
|
| Change in Other Net Operating Assets | 12.62 | 6.01 | 4.94 | -1.01 | 1.52 | -4.37 | Upgrade
|
| Operating Cash Flow | -260.29 | -249.47 | -172.58 | -81.37 | -159.81 | -84.37 | Upgrade
|
| Capital Expenditures | -11.56 | -14 | -9.27 | -8.4 | -12.24 | -5.66 | Upgrade
|
| Investment in Securities | 10.06 | 161.86 | -248.44 | 76.7 | 39.44 | -102.59 | Upgrade
|
| Investing Cash Flow | -1.51 | 147.85 | -257.71 | 68.3 | 27.2 | -108.25 | Upgrade
|
| Issuance of Common Stock | 257.14 | 238.64 | 485.68 | 3.22 | 22.43 | 164.13 | Upgrade
|
| Repurchase of Common Stock | - | - | -0.02 | - | - | - | Upgrade
|
| Other Financing Activities | - | - | - | - | 94.76 | -10.24 | Upgrade
|
| Financing Cash Flow | 257.14 | 238.64 | 485.67 | 3.22 | 117.19 | 153.88 | Upgrade
|
| Net Cash Flow | -4.65 | 137.03 | 55.37 | -9.85 | -15.42 | -38.73 | Upgrade
|
| Free Cash Flow | -271.85 | -263.47 | -181.86 | -89.77 | -172.05 | -90.03 | Upgrade
|
| Free Cash Flow Margin | -378.74% | -313.73% | -333.38% | -116.60% | -445.42% | -302.61% | Upgrade
|
| Free Cash Flow Per Share | -2.91 | -3.04 | -2.71 | -1.65 | -3.54 | -2.10 | Upgrade
|
| Cash Income Tax Paid | - | - | - | - | - | 0.48 | Upgrade
|
| Levered Free Cash Flow | -145.46 | -143.99 | -85.9 | -41.93 | -79.42 | -37.7 | Upgrade
|
| Unlevered Free Cash Flow | -145.46 | -143.99 | -85.9 | -41.93 | -79.42 | -37.7 | Upgrade
|
| Change in Working Capital | -13.67 | -31.6 | -18.4 | 20.12 | -19.02 | 9.11 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.